Astrana Health, Inc.
ASTH
$40.81
$3.027.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 109.48% | 115.72% | 186.30% | -97.68% | -50.85% |
| Total Depreciation and Amortization | 125.25% | 126.00% | 101.83% | 114.70% | -7.23% |
| Total Amortization of Deferred Charges | 9.25% | 64.11% | 155.07% | 152.08% | 128.54% |
| Total Other Non-Cash Items | -72.17% | 1.10% | -24.62% | 1.73% | 53.78% |
| Change in Net Operating Assets | -112.70% | 430.69% | -32.82% | -862.39% | 560.05% |
| Cash from Operations | -63.97% | 309.31% | 73.64% | -70.70% | 292.02% |
| Capital Expenditure | -173.10% | -30.29% | -21.06% | -11.20% | 49.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 99.83% | -60,246.86% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 304.96% | 71.01% | 7,722.22% | 439.26% | 102.61% |
| Cash from Investing | -478.27% | -18.80% | 96.83% | -6,492.71% | 98.65% |
| Total Debt Issued | -- | -- | -- | 45,385.53% | -100.00% |
| Total Debt Repaid | -2,842.91% | 97.21% | 2.65% | -1,285.76% | 57.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -155.94% | -0.64% | -887.44% | -30.18% | 72.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 87.79% | 98.09% | -- | -- | -- |
| Other Financing Activities | -153.11% | 101.03% | 389.05% | -1,046.03% | -72.63% |
| Cash from Financing | -1,104.84% | 63.87% | -72.51% | 20,428.87% | -118.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.53% | 264.52% | 49.14% | 446.54% | 955.94% |